The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis

Among the many new drug approved for the use of atopic dermatitis or eczema, dupilumab (Dupixent) is one of them. Find out about its evidence here.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Unmasking Endocrine Disruptors: The Invisible Chemicals Shaping Our Health

Endocrine-disrupting chemicals (EDCs) are a silent menace that infiltrate our daily lives, impacting our health in subtle yet significant ways. These stealthy substances can interfere with our hormonal balance, leading to a myriad of health issues. In Asia, where rapid industrialisation and urbanisation have intensified the presence of EDCs, understanding their sources, effects, and ways to reduce exposure is crucial. This article delves into the world of endocrine disruptors and their impact on Asia’s health landscape.

Read More »